Dr. Reddy's Laboratories, Inc. et al. v. Celgene Corporation > Summary
Court Case Number IPR2018-01509
Filing Date Aug 3, 2018
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesGrace Karaffa Obermann, Tina E. Hulse, Christopher G. Paulraj
Judge Writing the Final DecisionGrace Karaffa Obermann
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 11, 12, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
Petitioner
Patent Owner
Petitioner Attorneys
5Dr. Reddy's Laboratories
Attorney Name: Brandon M. White
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Emily J. Greb
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Crystal R. Canterbury
Perkins Coie
Dr. Reddy's Laboratories
Attorney Name: Kenneth Anderson
Dr. Reddy's Laboratories
Dr. Reddy's Laboratories
Attorney Name: Marc R. Levin
Perkins Coie
Patent Owner Attorneys
8Celgene
Attorney Name: Frank C. Calvosa
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Matthew J. Hertko
Jones Day
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Christopher J. Harnett
Jones Day
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: John Elsevier
Celgene
Celgene
Attorney Name: Cary Miller
Jones Day
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 07189740 | Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes | Mar 13, 2007 |
